OSUCCCOhio State University Comprehensive Cancer Center (Columbus, Ohio)
References in periodicals archive ?
Targeting the hedgehog pathway alone or in combination with the PI3K/AKT pathway could be a novel therapeutic option for treating tamoxifen-resistant breast cancer," said principal investigator Sarmila Majumder, research assistant professor in molecular and cellular biochemistry at the OSUCCC - James.
We are very proud of our researchers and clinicians, as this is the second molecule invented at OSUCCC to enter clinical trials within a year.
Leader Amanda Toland, assistant professor of medicine and a specialist in the genetics of cancer susceptibility at the OSUCCC - James and her collaborators analyzed 222 SCC tumors from 135 organ transplant recipients, who as a group are 65 to 250 times more likely to develop SCC than people in the general population.